<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35489367</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial.</ArticleTitle><Pagination><StartPage>851</StartPage><EndPage>862</EndPage><MedlinePgn>851-862</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(22)00125-4</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(22)00125-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">There are few evidence-based interventions for long COVID; however, holistic approaches supporting recovery are advocated. We assessed whether an online breathing and wellbeing programme improves health related quality-of-life (HRQoL) in people with persisting breathlessness following COVID-19.</AbstractText><AbstractText Label="METHODS">We conducted a parallel-group, single-blind, randomised controlled trial in patients who had been referred from one of 51 UK-based collaborating long COVID clinics. Eligible participants were aged 18 years or older; were recovering from COVID-19 with ongoing breathlessness, with or without anxiety, at least 4 weeks after symptom onset; had internet access with an appropriate device; and were deemed clinically suitable for participation by one of the collaborating COVID-19 clinics. Following clinical assessment, potential participants were given a unique online portal code. Participants were randomly assigned (1:1) to either immediate participation in the English National Opera (ENO) Breathe programme or to usual care. Randomisation was done by the research team using computer-generated block randomisation lists, with block size 10. The researcher responsible for randomisation was masked to responses. Participants in the ENO Breathe group participated in a 6-week online breathing and wellbeing programme, developed for people with long COVID experiencing breathlessness, focusing on breathing retraining using singing techniques. Those in the deferred group received usual care until they exited the trial. The primary outcome, assessed in the intention-to-treat population, was change in HRQoL, assessed using the RAND 36-item short form survey instrument mental health composite (MHC) and physical health composite (PHC) scores. Secondary outcome measures were the chronic obstructive pulmonary disease assessment test score, visual analogue scales (VAS) for breathlessness, and scores on the dyspnoea-12, the generalised anxiety disorder 7-item scale, and the short form-6D. A thematic analysis exploring participant experience was also conducted using qualitative data from focus groups, survey responses, and email correspondence. This trial is registered with ClinicalTrials.gov, NCT04830033.</AbstractText><AbstractText Label="FINDINGS">Between April 22 and May 25, 2021, 158 participants were recruited and randomly assigned. Of these, eight (5%) individuals were excluded and 150 participants were allocated to a treatment group (74 in the ENO Breathe group and 76 in the usual care group). Compared with usual care, ENO Breathe was associated with an improvement in MHC score (regression coefficient 2&#xb7;42 [95% CI 0&#xb7;03 to 4&#xb7;80]; p=0&#xb7;047), but not PHC score (0&#xb7;60 [-1&#xb7;33 to 2&#xb7;52]; p=0&#xb7;54). VAS for breathlessness (running) favoured ENO Breathe participation (-10&#xb7;48 [-17&#xb7;23 to -3&#xb7;73]; p=0&#xb7;0026). No other statistically significant between-group differences in secondary outcomes were observed. One minor self-limiting adverse event was reported by a participant in the ENO Breathe group who felt dizzy using a computer for extended periods. Thematic analysis of ENO Breathe participant experience identified three key themes: (1) improvements in symptoms; (2) feeling that the programme was complementary to standard care; and (3) the particular suitability of singing and music to address their needs.</AbstractText><AbstractText Label="INTERPRETATION">Our findings suggest that an online breathing and wellbeing programme can improve the mental component of HRQoL and elements of breathlessness in people with persisting symptoms after COVID-19. Mind-body and music-based approaches, including practical, enjoyable, symptom-management techniques might have a role supporting recovery.</AbstractText><AbstractText Label="FUNDING">Imperial College London.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Keir E J</ForeName><Initials>KEJ</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London, London, UK. Electronic address: k.philip@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owles</LastName><ForeName>Harriet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McVey</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagnuco</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunjes</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banya</LastName><ForeName>Winston</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollica</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lound</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patient Experience Research Centre, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zumpe</LastName><ForeName>Suzi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahams</LastName><ForeName>Amiad M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Clinical Health Psychology, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padmanaban</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Learning and Participation, English National Opera, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Brunel University London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalvani</LastName><ForeName>Ajit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkinson</LastName><ForeName>Nicholas S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04830033</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2022 Sep;10(9):815-816. doi: 10.1016/S2213-2600(22)00161-8</RefSource><PMID Version="1">35489368</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests SM, TP, KB, HB, JM, SZ, THH, and ALa work for ENO who developed and deliver ENO Breathe; however, the programme is delivered free of charge to participants. All other authors declare no competing interests. No authors have been paid to write this article by a pharmaceutical company or other agency.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35489367</ArticleId><ArticleId IdType="pmc">PMC9045747</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(22)00125-4</ArticleId><ArticleId IdType="pii">S2213-2600(22)00125-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: a meta-analysis and systematic review. medRxiv. 2021 doi: 10.1101/2021.11.15.21266377. published online Nov 16. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.15.21266377</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after COVID-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S, Philip KEJ, Williams P, et al. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward H, Flower B, Garcia PJ, et al. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Lancet. 2021;398:2057&#x2013;2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8580495</ArticleId><ArticleId IdType="pubmed">34774190</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs A, Vassall A. Count the cost of disability caused by COVID-19. Nature. 2021;593:502&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">34040204</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  NICE guideline (NG188) COVID-19 rapid guideline: managing the long-term effects of COVID-19. Version 1.7 (updated 23 Nov 2021) https://www.nice.org.uk/guidance/NG188</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9:1275&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research  Living with Covid19&#x2014;second review. https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</Citation></Reference><Reference><Citation>Ayoubkhani D, King S, Bosworth M, Pawelek P.  Office for National Statistics; 2022. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 6 January 2022.https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/6january2022</Citation></Reference><Reference><Citation>Norton A, Olliaro P, Sigfrid L, et al. Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis. 2021;21:601&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>Meagher T. Long COVID&#x2014;an early perspective. J Insur Med. 2021;49:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">33784738</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeloye D, Elneima O, Daines L, et al. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir Med. 2021;9:1467&#x2013;1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8372501</ArticleId><ArticleId IdType="pubmed">34416191</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D, Finn S.  World Health Organisation; 2019. What is the evidence on the role of the arts in improving health and well-being? A scoping review.https://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/publications/2019/what-is-the-evidence-on-the-role-of-the-arts-in-improving-health-and-well-being-a-scoping-review-2019</Citation><ArticleIdList><ArticleId IdType="pubmed">32091683</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrary JM, Altenm&#xfc;ller E, Kretschmer C, Scholz DS. The impact of music on health-related quality of life, as quantified by the SF-36: a systematic review and meta-analysis. medrxiv. 2021 doi: 10.1101/2021.11.30.21267066. published online Nov 30. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.30.21267066</ArticleId><ArticleId IdType="pmc">PMC8941357</ArticleId><ArticleId IdType="pubmed">35315920</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K, Lewis A, Hopkinson NS. Music and dance in chronic lung disease. Breathe (Sheff) 2019;15:116&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544789</ArticleId><ArticleId IdType="pubmed">31191722</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Cave P, Stern M, et al. Singing for lung health&#x2014;a systematic review of the literature and consensus statement. NPJ Prim Care Respir Med. 2016;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131649</ArticleId><ArticleId IdType="pubmed">27906158</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Cave P, Hopkinson NS. Singing for lung health: a qualitative assessment of a British Lung Foundation programme for group leaders. BMJ Open Respir Res. 2017;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5647539</ArticleId><ArticleId IdType="pubmed">29071079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Cave P, Hopkinson NS. Singing for lung health: service evaluation of the British Lung Foundation programme. Perspect Public Health. 2018;138:215&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">29757080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave P, Lewis A, Fancourt D. In: The Routledge companion to interdiciplinary studies in singing, volume III: wellbeing. Heydon R, Fancourt D, Cohen AJ, editors. Routledge; New York, NY: 2020. Singing for lung health; pp. 86&#x2013;97.</Citation></Reference><Reference><Citation>Philip KEJ, Katagira W, Jones R. Dance for respiratory patients in low-resource settings. JAMA. 2020;324:921&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">32897325</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KE, Lewis A, Jeffery E, et al. Moving singing for lung health online in response to COVID-19: experience from a randomised controlled trial. BMJ Open Respir Res. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689537</ArticleId><ArticleId IdType="pubmed">33239406</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K, Lewis A, Harrison S. Singing and dance for people with chronic breathlessness during the COVID-19 pandemic. 2020. https://www.thoracic.org/members/assemblies/assemblies/pr/quarterly-bite/singing-and-dance-for-people-with-chronic-breathlessness-during-the-covid-19-pandemic.php</Citation></Reference><Reference><Citation>Philip KEJ, Lewis A, Buttery SC, et al. Aerosol transmission of SARS-CoV-2: inhalation as well as exhalation matters for COVID-19. Am J Respir Crit Care Med. 2021;203:1041&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048753</ArticleId><ArticleId IdType="pubmed">33529544</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MJ, Yorke J, Hansen-Flaschen J, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49</Citation><ArticleIdList><ArticleId IdType="pubmed">28546269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77&#x2013;101.</Citation></Reference><Reference><Citation>Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33:350&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">11491194</ArticleId></ArticleIdList></Reference><Reference><Citation>Laucis NC, Hays RD, Bhattacharyya T. Scoring the SF-36 in orthopaedics: a brief guide. J Bone Joint Surg Am. 2015;97:1628&#x2013;1634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5029523</ArticleId><ArticleId IdType="pubmed">26446970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord VM, Hume VJ, Kelly JL, et al. Singing classes for chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med. 2012;12:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515466</ArticleId><ArticleId IdType="pubmed">23145504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frendl DM, Ware JE., Jr Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey. Med Care. 2014;52:439&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">24714581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Hopkinson NS. Tai chi movements for wellbeing&#x2014;evaluation of a British Lung Foundation pilot. Perspect Public Health. 2020;140:172&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">32414311</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan CM, Rochester CL. Exercise training modalities for people with chronic obstructive pulmonary disease. COPD. 2019;16:378&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">31684769</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KE, Lewis A, Buttery SC, et al. Physiological demands of singing for lung health compared with treadmill walking. BMJ Open Respir Res. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8162088</ArticleId><ArticleId IdType="pubmed">34045239</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>World Physiotherapy . World Physiotherapy; London: 2021. World Physiotherapy response to COVID-19 briefing paper 9: safe rehabilitation approaches for people living with long COVID: physical activity and exercise.</Citation></Reference><Reference><Citation>Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, borg scale, and visual analog scale. COPD. 2005;2:105&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">17136970</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockley JA, Alhuthail EA, Coney AM, et al. Lung function and breathing patterns in hospitalised COVID-19 survivors: a review of post-COVID-19 clinics. Respir Res. 2021;22:255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474952</ArticleId><ArticleId IdType="pubmed">34579722</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>